UNITED THERAPEUTICS Corp Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
UNITED THERAPEUTICS Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • UNITED THERAPEUTICS Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $79.5M, a 5.58% decline year-over-year.
  • UNITED THERAPEUTICS Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $327M, a 26.8% increase year-over-year.
  • UNITED THERAPEUTICS Corp annual Income Tax Expense (Benefit) for 2023 was $290M, a 29.6% increase from 2022.
  • UNITED THERAPEUTICS Corp annual Income Tax Expense (Benefit) for 2022 was $223M, a 89.1% increase from 2021.
  • UNITED THERAPEUTICS Corp annual Income Tax Expense (Benefit) for 2021 was $118M, a 4.84% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $327M $79.5M -$4.7M -5.58% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $332M $77.2M +$1.2M +1.58% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $331M $92M +$41M +80.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $290M $78.3M +$31.6M +67.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $258M $84.2M +$11M +15% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $247M $76M +$41.4M +120% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $206M $51M -$17.8M -25.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $223M $46.7M +$18.4M +65% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $205M $73.2M +$31.5M +75.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $173M $34.6M -$9.3M -21.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $183M $68.8M +$64.6M +1538% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $118M $28.3M +$12.7M +81.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $105M $41.7M -$6.1M -12.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $112M $43.9M +$17.1M +63.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $94.4M $4.2M -$29.7M -87.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $124M $15.6M -$100K -0.64% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $124M $47.8M +$13.3M +38.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $111M $26.8M -$18.5M -40.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $129M $33.9M +$190M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$60.5M $15.7M -$10.9M -41% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$49.6M $34.5M +$900K +2.68% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 -$50.5M $45.3M +$300K +0.67% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$50.8M -$156M -$221M -342% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $170M $26.6M -$95.4M -78.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $265M $33.6M -$10.8M -24.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $276M $45M -$55.2M -55.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $331M $64.5M -$20.5M -24.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $352M $122M +$60.8M +99.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $291M $44.4M -$32.9M -42.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $324M $100M +$20.6M +25.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $303M $85M -$43.4M -33.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $347M $61.2M +$9.8M +19.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $337M $77.3M -$195M -71.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 $532M $79.6M +$10.4M +15% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $521M $128M +$129M Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $393M $51.4M -$7.42M -12.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 $400M $272M +$283M Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 $117M $69.2M +$8.02M +13.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $109M -$200K -$75.9M -100% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 $185M $58.8M +$60.1M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 $125M -$10.6M -$49.1M -128% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $174M $61.2M +$22.5M +58.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-28
Q1 2014 $152M $75.7M +$47.2M +165% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $104M -$1.32M -$43M -103% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 $147M $38.5M +$8.11M +26.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $139M $38.7M +$7.68M +24.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 $132M $28.5M -$4.67M -14.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 $136M $41.7M +$25.6M +160% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $111M $30.4M +$12.7M +72.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $97.9M $31M -$4.75M -13.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $103M $33.2M +$20.7M +167% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $81.9M $16.1M +$19.4M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $62.4M $17.6M -$576K -3.16% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $63M $35.7M +$16.4M +84.7% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-26
Q1 2011 $46.6M $12.4M +$2.69M +27.6% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $43.9M -$3.37M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $18.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $19.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $9.75M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.